A RARE CASE OF HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY IN 13 YEAR OLDFEMALE PATIENT-SURGICALLY MANAGED
Abstract
Hocm is one of the causes of sudden
deaths, it is comon in the 3rd and 4th
decade,it is not comon in adolescents, but
if present, surgical resection done early is
the main mode of treatment.
Full Text:
PDFReferences
Braunwald E, Lambrew CT, Rockoff
SD, Ross J Jr, Morrow AG. Idiopathic
hypertrophic subaortic stenosis. I. A
description of the disease based upon
an analysis of 64 patients. Circulation
;30:Suppl IV:IV-3–IV-119.
Maron BJ. Hypertrophic cardiomyopathy:
a systematic review. JAMA
;287: 1308-20.
Wigle ED, Sasson Z, Henderson MA,
et al. Hypertrophic cardiomyopathy: the
importance of the site and the extent of
hypertrophy: a review. Prog Cardiovasc
Dis 1985;28: 1-83.
Marian AJ, Roberts R. Recent advances
in the molecular genetics of hypertrophic
cardiomyopathy. Circulation
;92:1336-47.
Braunwald E, Seidman CE, Sigwart
U. Contemporary evaluation and management
of hypertrophic cardiomyopathy.
Circulation 2002;106:1312-6.
Epstein SE, Rosing DR. Verapamil:
its potential for causing serious complications
in patients with hypertrophic
c a r d iom yopa t h y . C i r cul a t ion
;64:437-41.
Pollick C. Muscular subaortic stenosis:
hemodynamic and clinical improvement
after disopyramide. N Engl J Med
;307: 997-9.
Morrow AG. Hypertrophic subaortic
stenosis: operative methods utilized to
relieve left ventricular outflow obstruction.
J Thorac Cardiovasc Surg
;76:423-30.
McCully RB, Nishimura RA, Tajik AJ,
Schaff HV, Danielson GK. Extent of clinical
improvement after surgical treatment of
hypertrophic obstructive cardiomyopathy.
Circulation 1996;94:467-71.
Schulte HD, Borisov K, Gams E,
Gramsch-Zabel H, Losse B, Schwartzkopff
B. Management of symptomatic hypertrophic
obstructive cardiomyopathy — longterm
results after surgical therapy. Thorac
Cardiovasc Surg 1999;47:213-8.
Fananapazir L, Epstein ND, Curiel RV,
Panza JA, Tripodi D, McAreavey D. Longterm
results of dual-chamber (DDD) pacing
in obstructive hypertrophic cardiomyopathy:
evidence for progressive symptomatic
and hemodynamic improvement
and reduction of left ventricular hypertrophy.
Circulation 1994;90:2731-42.
Nishimura RA, Trusty JM, Hayes DL, et
al. Dual-chamber pacing for hypertrophic
cardiomyopathy: a randomized, doubleblind,
crossover study. J Am Coll Cardiol
;29:435-41.
Maron BJ, Nishimura RA, McKenna
WJ, Rakowski H, Josephson ME, Kieval
RS. Assessment of permanent dualchamber
pacing as a treatment for drugrefractory
symptomatic patients with obstructive
hypertrophic cardiomyopathy: a
randomized, double-blind, crossover study
(MPATHY). Circulation 1999;99:2927-33.
Nishimura RA, Symanski JD, Hurrell
DG, Trusty JM, Hayes DL, Tajik AJ. Dualchamber
pacing for cardiomyopathies: a
clinical perspective. Mayo Clin Proc
;71:1077-87.
Ommen SR, Nishimura RA, Squires
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
An Initiative of The Tamil Nadu Dr MGR Medical University